EN
HI
Summary
As of 15 Sep, 2026, Aspira Pathlab & Diagnostics stock price is ₹97. During the trading session, the stock has moved between an intraday low of ₹90.35 and an intraday high of ₹99.59. Over the last 52 weeks, Aspira Pathlab & Diagnostics has traded between ₹49.00 and ₹135.88.
The stock has recorded a trading volume of 448 shares,. Its Average Traded Price (ATP) is ₹92.77, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 20 @ ₹97.00.
Aspira Pathlab & Diagnostics has an upper circuit limit of ₹99.75 and a lower circuit limit of ₹90.25. The total value traded stands at ₹41560.96, and the delivery percentage for the day is 100%.
The stock is currently traded with a market lot size of 1. Aspira Pathlab & Diagnostics also offers a dividend yield of 0%.
Aspira Pathlab & Diagnostics Share Price Chart
Aspira Pathlab & Diagnostics Share Key Metrics
Volume
448.00
Market Cap
97.78 CR
LTQ@LTP
20@97.00
ATP
92.77
Var Margin
28.42 %
Circuit Range
90.25-99.75
Delivery %
100 %
Value
41560.96
ASM/GSM
No
Market Lot
1
Aspira Pathlab & Diagnostics Fundamentals
P/E Ratio
40.76
P/B Ratio
7.74
Div. Yield
0
Sector P/E
56.41
Sector P/B
-13.64
Sec. Div. Yield
0.17
Aspira Pathlab & Diagnostics Resistance and Support
Pivot 94.02
Resistance
First Resistance
96
Second Resistance
96.99
Third Resistance
98.97
Support
First Support
93.03
Second Support
91.05
Third Support
90.06
Aspira Pathlab & Diagnostics Historical Data
| Day | Open | Close | Change(%) | Day High | Day Low |
|---|---|---|---|---|---|
| Tue Sep 15 2026 | 95 | 97 | 2.11% | 99.59 | 90.35 |
| Fri Sep 11 2026 | 95.01 | 95 | 0.48% | 95.01 | 92.04 |
| Thu Sep 10 2026 | 94.55 | 94.55 | 2.00% | 95.01 | 94.55 |
Aspira Pathlab & Diagnostics Corporate Actions
| Date | Agenda |
|---|---|
| 2026-09-12 | Others |
| 2026-08-12 | Quarterly Results & Raising of funds |
| 2026-05-23 | Audited Results |
| 2026-02-10 | Quarterly Results |
| 2025-11-12 | Quarterly Results |
| 2025-08-12 | Quarterly Results |
| 2025-05-16 | Audited Results |
| 2025-02-07 | Quarterly Results |
| 2024-11-12 | Quarterly Results |
| 2024-08-13 | Quarterly Results |
Aspira Pathlab & Diagnostics News
Aspira Pathlab & Diagnostics Ltd - 540788 - Announcement Under Regulation 30_Constitution Of Right Issue Committee
Aspira Pathlab's board approved raising funds not exceeding Rs. 65 crore through a Rights Issue to eligible equity shareholders. A Right Issue Committee has been constituted to finalize the terms and conditions, including the record date and issue price.
Sep 12 2026 16:57:53
Aspira Pathlab & Diagnostics Ltd - 540788 - Announcement under Regulation 30 (LODR)-Raising of Funds
Aspira Pathlab board has approved a rights issue to raise funds not exceeding Rs. 65 crore. This capital will be raised from eligible equity shareholders, subject to shareholder and regulatory approvals. A committee has been constituted to finalize the terms and conditions of the issue, including record date and price.
Sep 12 2026 16:52:24
Read More
Aspira Pathlab & Diagnostics Management
| Name | Position |
|---|---|
| Haseeb A Drabu | Chairman |
| Pankaj Shah | Managing Director & Chief Executive Officer |
Aspira Pathlab & Diagnostics Similar Stocks
Bharat Immunologicals & Biologicals Corporation Ltd.
15.02
-0.09 (0.60%)
Pharmaids Pharmaceuticals Ltd.
29.75
-0.56 (1.85%)
Concord Drugs Ltd.
79.95
0.28 (0.35%)
Everest Organics Ltd.
250.80
-14.30 (5.39%)
Godavari Drugs Ltd.
112.00
-7.04 (5.91%)
Kretto Syscon Ltd.
0.42
-0.01 (2.33%)
Vasundhara Rasayans Ltd.
153.95
7.00 (4.76%)
Aspira Pathlab & Diagnostics FAQs
The Buying Price of Aspira Pathlab & Diagnostics share is 97 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Aspira Pathlab & Diagnostics stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Aspira Pathlab & Diagnostics, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Aspira Pathlab & Diagnostics shares is 40.76. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Aspira Pathlab & Diagnostics shares is 7.74. Useful to assess the stock's value relative to its book value.
To assess Aspira Pathlab & Diagnostics’s valuation compare Sector P/E, P/B which are 56.41 & -13.64 with sector averages, along with growth rates and financial metrics.
The Market Cap of Aspira Pathlab & Diagnostics is 97.78 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Aspira Pathlab & Diagnostics share price is 135.88 & 49.00. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Aspira Pathlab & Diagnostics belongs to the Healthcare sector.
Open Your Free
Demat Account Now!
AMC for First Year- Auto Square Off Charges
13 Lakh+ Clients
Expert-Backed
Premium Tools
Open Your Free
Demat Account Now!
- AMC For First Year
- Account Opening Fee
- 13 Lakh+ Clients
- Expert-Backed
- Premium Tools
Invest in ASPIRA
